Human Microbiome Drug Targets

Modern Approaches in Disease Management
Herausgeber: Dable-Tupas, Genevieve; B Otero, Maria Catherine; C Lim, Peter Paul; Karunakaran, Rohini

• Broschiertes Buch

Produktbeschreibung

Human Microbiome Drug Targets: Modern Approaches in Disease Management presents fundamental information on the human microbiome, looking into the relationship between the microbiome and how it changes with specific diseases. Delving into the multifaceted roles of the microbiome in health and disease, the book's chapters discuss the role of the human microbiome in the pathophysiologic understanding of relevant diseases or disorders and their management. As changes in the human microbiome can provide clues to the probable cause and effect of diseases or disorders, as well as the impacts of therapy or intervention, this book is a welcomed addition to the existing research. Explaining how a better understanding of the microbiome and its impact on health and disease can pave the way for future discoveries leading to better health outcomes, this book will be of interest to drug developers, medicinal chemists, microbiologists, infectious disease specialists, biochemists, and students.

Produktdetails

• Verlag: Elsevier Health Sciences
• Seitenzahl: 350
• Erscheinungstermin: 1. Oktober 2024
• Englisch
• Abmessung: 229mm x 152mm
• ISBN-13: 9780443154355
• ISBN-10: 044315435X
• Artikelnr.: 68139660

Inhaltsangabe

Part One: Foundational Information 1. Tracing the History of Microbiome
Evolution 2. The Human Microbiome: An Overview 3. The GUT Microbiome 4. The
Microbiome and One Health Approach 5. Overview of Human Microbiome and Drug
Discovery Part Two: Human Microbiome in Health and Disease 6. Human
Microbiome and Nutrition 7. Human Microbiome and Mental Health 8. Human
Microbiome and Diabetes 9. Human Microbiome and Cancer and Cancer Therapy
10. Human Microbiome, Obesity and Cardiovascular Diseases 11. Human
Microbiome and Respiratory Diseases 12. Human Microbiome and Liver Diseases
13. Human Microbiome and Neuro-Developmental Disorders 14. Human Microbiome
and Inflammatory Diseases Part Three: Microbiome and Drug Discovery 15. The
Human Microbiome as Drug Targets 16. Microbiome-Based Therapeutics
(Including Probiotics, Prebiotics and Symbiotics) 17. Microbiome Metabolite
Based Therapies 18. Role of Nanotechnology in Microbiome Drug Development
19. Microbiome-Based Therapies on Trial